Literature DB >> 15564821

Practice parameter for use of electroconvulsive therapy with adolescents.

Neera Ghaziuddin, Stanley P Kutcher, Penelope Knapp, William Bernet, Valerie Arnold, Joseph Beitchman, R Scott Benson, Oscar Bukstein, Joan Kinlan, Jon McClellan, David Rue, Jon A Shaw, Saundra Stock, Kristin Kroeger Ptakowski.   

Abstract

Electroconvulsive therapy (ECT) may be an effective treatment for adolescents with severe mood disorders and other Axis I psychiatric disorders when more conservative treatments have been unsuccessful. ECT may be considered when there is a lack of response to two or more trials of pharmacotherapy or when the severity of symptoms precludes waiting for a response to pharmacological treatment. The literature on ECT in adolescents, including studies and case reports, was reviewed and then integrated into clinically relevant guidelines for practitioners. Mood disorders have a high rate of response to ECT (75%-100%), whereas psychotic disorders have a lower response rate (50%-60%). Consent of the adolescent's legal guardian is mandatory, and the patient's consent or assent should be obtained. State legal guidelines and institutional guidelines must be followed. ECT techniques associated with the fewest adverse effects and greatest efficacy should be used. The presence of comorbid psychiatric disorder is not a contraindication. Systematic pretreatment and posttreatment evaluation, including symptom and cognitive assessment, is recommended.

Entities:  

Mesh:

Year:  2004        PMID: 15564821     DOI: 10.1097/01.chi.0000142280.87429.68

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  23 in total

1.  Acute Phase Treatment Outcomes of Electroconvulsive Therapy in Adolescents and Young Adults.

Authors:  Nicole M Benson; Stephen J Seiner; Paula Bolton; Garrett Fitzmaurice; Robert C Meisner; Casey Pierce; Alisa B Busch
Journal:  J ECT       Date:  2019-09       Impact factor: 3.635

Review 2.  Psychopharmacologic treatment of pediatric major depressive disorder.

Authors:  Khrista Boylan; Soledad Romero; Boris Birmaher
Journal:  Psychopharmacology (Berl)       Date:  2006-08-08       Impact factor: 4.530

Review 3.  Catatonia in patients with autism: prevalence and management.

Authors:  Luigi Mazzone; Valentina Postorino; Giovanni Valeri; Stefano Vicari
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

Review 4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

Authors:  Glenda M MacQueen; Benicio N Frey; Zahinoor Ismail; Natalia Jaworska; Meir Steiner; Ryan J Van Lieshout; Sidney H Kennedy; Raymond W Lam; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

5.  Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders.

Authors:  Itziar Flamarique; Inmaculada Baeza; Elena de la Serna; Alexandre Pons; Miguel Bernardo; Josefina Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-09-03       Impact factor: 4.785

Review 6.  Treatments in child and adolescent bipolar disorders.

Authors:  Angèle Consoli; Emmannuelle Deniau; Christophe Huynh; Diane Purper; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-11-29       Impact factor: 4.785

Review 7.  The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression.

Authors:  Paul E Croarkin; Christopher A Wall; Shawn M McClintock; Frank Andrew Kozel; Mustafa M Husain; Shirlene M Sampson
Journal:  J ECT       Date:  2010-12       Impact factor: 3.635

8.  Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: a retrospective study.

Authors:  Angele Consoli; Johan Cohen; Nicolas Bodeau; Vincent Guinchat; Lee Wachtel; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-08-25       Impact factor: 4.785

Review 9.  Management of treatment-resistant depression in children and adolescents.

Authors:  Melissa DeFilippis; Karen Dineen Wagner
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

10.  Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia.

Authors:  Angèle Consoli; Valérie Boulicot; Françoise Cornic; Philippe Fossati; Martine Barbeau; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-01-20       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.